Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Capital Expenditures: 2020-2024

Historic Capital Expenditures for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $653,288.

  • iSpecimen's Capital Expenditures rose 611.90% to $999,546 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 61.24%. This contributed to the annual value of $653,288 for FY2024, which is 82.66% down from last year.
  • Per iSpecimen's latest filing, its Capital Expenditures stood at $653,288 for FY2024, which was down 82.66% from $3.8 million recorded in FY2023.
  • Over the past 5 years, iSpecimen's Capital Expenditures peaked at $3.8 million during FY2023, and registered a low of $653,288 during FY2024.
  • Over the past 3 years, iSpecimen's median Capital Expenditures value was $3.0 million (recorded in 2022), while the average stood at $2.5 million.
  • As far as peak fluctuations go, iSpecimen's Capital Expenditures surged by 187.40% in 2022, and later crashed by 82.66% in 2024.
  • Yearly analysis of 5 years shows iSpecimen's Capital Expenditures stood at $1.1 million in 2020, then fell by 6.06% to $1.0 million in 2021, then soared by 187.40% to $3.0 million in 2022, then climbed by 26.60% to $3.8 million in 2023, then tumbled by 82.66% to $653,288 in 2024.